2024年4月25日 · At PathAI, we’re dedicated to improving patient outcomes with reliable AI-Powered technology and meaningful collaboration with biopharma and pathology laboratories — aiming to provide invaluable insights for biomarker discovery and drug development, and to improve laboratory workflows.

PathAI Ranked 420th Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™. PathAI Announces Integrations with Leading AI-pathology companies Deep Bio, DoMore Diagnostics, Paige, and Visiopharm, through its …

2021年7月4日 · PathAI 的医疗设备能力允许针对跨疾病领域和生物制药产品组合的靶向治疗算法的规范开发。PathAI的平台利用与临床实验室和设备制造商的合作伙伴关系进行全球商业化。 PathAI, inc.融资百科

2023年1月16日 · Capitalizing on the 30-year history of delivering high quality pathology services in the PathAI Diagnostics clinical laboratory (formerly known as Poplar Healthcare), PathAI offers biopharma partners a comprehensive, GCP/GCLP compliant histology and digital pathology lab to support prospective clinical trials across oncology, liver, and ...

2024年4月21日 · PathAI 的主要目标是为患者提供准确的诊断和有效的治疗，从而推动医学领域的发展。 AI 驱动的病理学：先进的 AI 算法用于准确和高效的诊断。 AISight™ 数字病理图像管理系统：数字病理学中的企业工作流程的云原生解决方案。 生物制药服务：用于药物和诊断开发的综合服务。 广泛的病理医生网络：超过 450 名董事会认证的病理医生为 AI 训练和验证做出贡献。 精准医疗：利用 AI 推动个性化治疗方法的发展。 研究和开发支持：AI 驱动的工具辅助突破性的医 …

2021年5月18日，一家以人工智能（AI）驱动的病理学技术全球提供商PathAI宣布完成了1.65亿美元的C轮融资。PathAI将部署其新的资本来加速产品开发，同时继续以可靠的AI驱动技术和与医药诊断合作伙伴的合作来改善患者生活质量。

2016年1月1日 · PathAI是病理实验室使用AI技术的全球领先提供商。 PathAI的服务解决了研究和制药行业面临的最具挑战性的病理学问题。 PathAI平台为可靠、可扩展和经济高效的长期解决方案提供端到端自动化。

PathAI's mission is to improve patient outcomes with AI-powered pathology. Their platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine learning.

BOSTON — August 25, 2022 — PathAI, a global leader in AI-powered pathology, today announced a multi-year expanded collaboration agreement with Bristol Myers Squibb. The initial work within this extended agreement will focus on key translational research in oncology, fibrosis, and immunology, with an overall goal to continue transitioning ...

PathAI’s services solve challenging pathology problems faced by the research and pharmaceutical industry. The PathAI platform provides end-to-end automation for reliable, scalable, and cost-effective long-term solutions. PathAI is developing technology that assists pathologists in making accurate diagnoses for every patient, every time. The